Both Charles Rudin, MD, PhD, and Andrew Nicholson, MD, were recognized by the International Association for the Study of Lung Cancer (IASLC) at the IASLC 2019 World Conference on Lung Cancer (WCLC). The 19th WCLC, the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology, was held September 7 to 10, 2019 in Barcelona.
Charles Rudin, MD, PhD
Andrew Nicholson, MD
Charles Rudin, MD, PhD, was recognized by IASLC with the Paul A. Bunn, Jr. Scientific Award. The award recognized Dr. Rudin’s lifetime achievement in scientific contributions to thoracic cancer research.
Dr. Rudin is the Sylvia Hassenfeld Professor and Chief of Thoracic Oncology at Memorial Sloan Kettering Cancer Center (MSK), where he also is Co-Director of the Druckenmiller Center for Lung Cancer Research. At MSK, he oversees a broad and integrated program of preclinical and clinical research in lung cancer.
Dr. Rudin has an interest in small cell lung cancer (SCLC) and chairs the National Cancer Institute’s SCLC Research Consortium, a national network of investigators studying SCLC oncogenesis, mouse and human preclinical modeling, genomic and epigenetic drivers, and therapeutic vulnerabilities. He also serves as the MSK Primary Investigator for two Stand Up To Cancer grants.
Andrew Nicholson, MD, was recognized by IASLC with the Mary J. Matthews Pathology/Translational Research award. Dr. Nicholson, Professor in Respiratory Pathology, was honored for his lifetime scientific achievements in pathology/translational research of thoracic malignancies.
Dr. Nicholson is the past Chair of the IASLC Pathology Panel as well as a long-standing member of the IASLC Staging and Prognostic Factors Committee and the IASLC Membership Committee. He was on the Specialist Advisory Panel for the Royal College of Pathologists for the past decade and is President-Elect of the British Division of the International Academy of Pathologists.
Dr. Nicholson trained in medicine at Oxford University and St. Bartholomew’s Medical School and then specialized in thoracic pathology at the Royal Brompton Hospital. He is an honorary Professor in Respiratory Pathology at the National Heart and Lung Institute, Imperial College in London.
Dr. Nicholson’s research has been referred to in over 300 cases each year, mainly related to cancer, from clinicians and other pathologists, both nationally and internationally. His research interests are common and rare lung cancers, mesotheliomas, thymic tumors, and other thoracic diseases (such as interstitial lung disease).
Dr. Nicholson coauthored the medical text Pathology of the Lung, second and third editions, with Byran Corrin. He was a volume editor of the 2015 World Health Organization Classification of Lung, Pleura, Thymus, and Heart Tumors. He is also the author of the AFIP Atlas of Tumor Pathology: Tumors of the Lower Respiratory Tract. ■